ClinVar Miner

Submissions for variant NM_001943.5(DSG2):c.1773_1774del (p.Cys591_Glu592delinsTer) (rs397516703)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000037271 SCV000060928 pathogenic Arrhythmogenic right ventricular cardiomyopathy 2018-04-23 criteria provided, single submitter clinical testing proposed classification - variant undergoing re-assessment, contact laboratory
GeneDx RCV000181243 SCV000233522 pathogenic not provided 2014-04-17 criteria provided, single submitter clinical testing At least 12% of patients with autosomal dominant arrhythmogenic right ventricularcardiomyopathy (ARVC) have been reported to have a mutation in the DSG2 gene (McNally E et al., 2009). The c.1773_1774delTG mutation in the DSG2 gene has been previously reported in association with ARVC (Syrris et al., 2007; Sen-Chowdhry et al., 2008; Asimaki et al., 2009). Syrris et al. (2007) identified this mutation 2 individuals in the same family who met TFC for ARVC, and c.1773_1774delTG was not identified in 400 healthy, ethnically-matched control alleles. Furthermore, the c.1773_1774delTG mutation was not observed inapproximately 6300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This mutation causes a shift in reading frame starting at codon Cysteine 591, which creates a premature stop codon at this position, denoted as p.Cys591Stop. This mutation is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift and nonsense mutations in the DSG2 gene have been reported in association with ARVC. In summary, c.1773_1774delTG in the DSG2 gene is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.